TAMARA CROWELL: Open Payments
NPI 1497909451 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,829 in 135 payments from 33 companies in 2025. Trend: 2023 $3,738 · 2024 $3,502 · 2025 $2,829
Food & beverage: $2,829
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $287 |
| AstraZeneca Pharmaceuticals LP | 11 | $222 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $208 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $188 |
| Corcept Therapeutics | 8 | $166 |
| Recor Medical Inc | 1 | $166 |
| Abbott Laboratories | 11 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $151 |
| ABBVIE INC. | 9 | $144 |
| Novo Nordisk Inc | 7 | $126 |
Products named: JARDIANCE, CAPLYTA, JYNARQUE, Korlym, Paradise Ultrasound Renal Denervation System, FREESTYLE LIBRE 3, Kerendia, REXULTI.
Industry payments across FL — which companies pay providers there.
